摘要 |
<p>Use of tetracyclic derivatives of general formula (I) and pharmaceutically acceptable salts and solvates (e. g. hydrates) thereof, in which R0 represents H, halogen or alkyl containing 1 to 6 carbon atoms; R1 represents H, alkyl containing 1 to 6 carbon atoms, alkenyl or alkynyl, each of them containing 1 to 6 carbon atoms, haloalkyl containing 1 to 6 carbon atoms, cykloalkyl containing 3 to 8 carbon atoms, cykloalkylalkyl containing 3 to 8 carbon atoms in the cykloalkyl moiety and 1 to 3 carbon atoms in the alkyl moiety, an optionally substituted phenylalkyl containing 1 to 3 carbon atoms in the alkyl moiety or an optionally substituted heteroarylalkyl containing 1 to 3 carbon atoms in the alkyl moiety, wherein heteroaryl is represented by thienyl, furyl or pyridyl; R2 represents an optionally substituted monocyclic aromatic ring selected from benzene, thiophene, furan and pyridine or an optionally substituted bicyclic system; and R3 represents H or alkyl containing 1 to 3 carbon atoms; or R1 and R3 together represent a 3- or 4-membered alkyl or alkenyl chain; for the manufacture of a medicament for the treatment or prophylaxis of female sexual dysfunction such as orgasmic dysfunction. The medicament is preferably in the form suitable for oral administration.</p> |